PARTNER II Trial: S3iCAP
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1822 participants.
Also called NCT02687035
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,822 participants
- Sponsor
- Registry
-
NCT02687035
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02687035. Allocation not applicable; no masking; primary purpose treatment. Start 2015-01 (actual); primary completion 2017-10 (actual). Results posted on 2021-04-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PARTNER II Trial: S3iCAP
- Acronym
- PII S3i CAP
- Condition
- Aortic Stenosis
- Intervention (Device)
- SAPIEN S3 valve
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct02687035- Content hash
d85c53fdee4f58d0b2b647d1a2e7c2a175ceba83e04a2d67bdb4cc6b9a8226ef